U.S. Markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
48.75+1.57 (+3.33%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close47.18
Open47.18
Bid48.68 x 1000
Ask48.70 x 900
Day's Range46.20 - 49.25
52 Week Range42.19 - 125.00
Volume719,392
Avg. Volume1,010,515
Market Cap1.606B
Beta (5Y Monthly)1.71
PE Ratio (TTM)N/A
EPS (TTM)-10.74
Earnings DateAug 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est66.32
  • Why Earnings Season Could Be Great for Intercept (ICPT)
    Zacks

    Why Earnings Season Could Be Great for Intercept (ICPT)

    Intercept (ICPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Did Hedge Funds Make The Right Call On Intercept Pharmaceuticals Inc (ICPT)?
    Insider Monkey

    Did Hedge Funds Make The Right Call On Intercept Pharmaceuticals Inc (ICPT)?

    At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]

  • GlobeNewswire

    Intercept to Announce Second Quarter 2020 Financial Results on August 10, 2020

    NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its second quarter 2020 financial results prior to market open on Monday, August 10, 2020. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results. The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 5073644. Archived webcasts will be available on Intercept’s website for approximately two weeks.About Intercept Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.CONTACTFor more information about Intercept, please contact:> Investor inquiries: investors@interceptpharma.com> > Media inquiries: media@interceptpharma.comSource: Intercept Pharmaceuticals, Inc.